JPRN-UMIN000004968
Recruiting
未知
A pharmacogenomics study for adverse effects and clinical outcome to S-1 in gastric cancer patients - Pharmacogenomics study for individual response to S-1
Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka0 sites100 target enrollmentFebruary 10, 2011
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Known prior severe hypersensitivity to clinical trial medicines 2\) Patients who do not have enough whole body state to the antineoplastic agents treatment 3\) Pregnant, breastfeeding or expecting woman 4\) Other clinical difficulties in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A study to identify clinical and inborn risk factors for development of vision impairment in patients on Ethambuol, an antituberculosis drugCTRI/2022/08/045044Duke NUS Program Grant Award
Completed
Not Applicable
Genome analysis on drug adverse reactioMalignant diseasesJPRN-UMIN000015784Department of Medical Oncology Graduate School of Medicine, Chiba University55
Recruiting
Not Applicable
Pharmacogenetic analysis to investigate the association between efficacy and neurotoxicity of oxaliplatin and single nucleotide polymorphismsColorectal cancerJPRN-UMIN000002490Kyoto University Hospital133
Completed
Not Applicable
adverse drug reactions and quality of life with anti-hiv treatmentHealth Condition 1: null- HIV positiveCTRI/2019/02/017398Dr Ruchika Irene Dillu100
Completed
Not Applicable
Adverse effects of COVID VACCINESCTRI/2021/06/034208YENEPOYA MEDICAL COLLEGE100